ArticleSurgery today2026
Safe introduction of uniportal video-assisted thoracoscopic surgery in an academic center: the learning process and training implications.
Article in Surgery today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWe evaluated the perioperative outcomes and learning process during the introduction of uniportal video-assisted thoracoscopic surgery (uVATS) at a university hospital.
methodsuVATS was initiated by two experienced thoracic surgeons using a safety-oriented, stepwise approach with a flexible team rotation. We retrospectively reviewed 83 consecutive patients (84 lesions) who underwent uVATS between October 2020 and December 2024 for clinically node-negative primary lung cancer or metastatic lung tumors. Learning patterns were analyzed using the cumulative sum (CUSUM) of the operative time.
resultsThe procedures included 46 lobectomies and 38 segmentectomies (23 complex). No conversion to thoracotomy occurred; four cases (4.8%) required conversion to multiportal VATS (mVATS) owing to lymph node dissection difficulty. The median operative time was 174 min, and reoperation was performed in two patients (2.4%). Among the 84 lesions, 76 were primary lung cancers, and eight were non-primary lesions. Among the primary lung cancer cases, the median tumor size was 19.0 mm. Most patients had early stage disease, including stage 0 (n = 5), stage IA1 (n = 17), stage IA2 (n = 19), stage IA3 (n = 14), and stage IB (n = 12), whereas a smaller proportion had more advanced disease (stage IIA, n = 2; stage IIB, n = 4; stage IIIA, n = 3). During a median follow-up period of 2.6 years, tumor recurrence was observed in five patients, including two cases of local recurrence. A CUSUM analysis did not demonstrate a distinct early learning phase, and operative performance remained relatively stable from the initial cases.
conclusionsuVATS was safely introduced without any early performance deterioration, likely reflecting the transfer of skills from prior open and mVATS experience.
Indexed as
Identifiers
42420671What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.